Endocrinology & Diabetes

Structured specialty care on Frappe Health for endocrine and diabetes clinics

Techunison’s endocrinology digital clinic model turns fragmented follow-up into a connected specialty workflow. It combines structured SOAP, diabetes scorecards, care-gap alerts, referral logic, patient recall, and dashboard visibility in one operational framework.

Talk to an expert

Request a Demo

1 platform

Endocrinology encounter, longitudinal follow-up, remote monitoring, and specialty analytics

5-step flow

Check-in, nurse intake, specialist review, background scoring, recall closure

360° view

Clinical risk, service quality, due screenings, wearable alerts, and chronic care performance

The challenge in endocrinology and diabetes care

Endocrinology is not a one-visit specialty. Diabetes, thyroid disease, obesity, PCOS, and metabolic disorders require repeatable workflows, longitudinal tracking, and care-gap closure across multiple visits.

What usually breaks down

SOAP notes vary by clinician and are difficult to analyze later.

HbA1c, BMI, blood pressure, thyroid panels, foot exams, retina screening, and adherence checks are captured inconsistently.

High-risk patients are not automatically surfaced for tighter follow-up.

Patient education, counseling, and care coordinator steps are not closed in a structured way.

Leadership has limited visibility into endocrine program quality across doctors or locations.

What specialty programs actually need

Standardized specialist consultation templates

Background risk scoring without increasing clinician burden

Longitudinal diabetes and endocrine tracking

Referral and screening reminders built into the visit workflow

Dashboards that show both clinical risk and service quality

The Techunison approach

We use Frappe Health as the operating foundation and add a specialty layer that supports endocrine practice from nurse intake to specialist decision-making to chronic care reporting.

Structured specialty encounters

Guided endocrinology templates for diabetes follow-up, thyroid review, obesity management, PCOS, and chronic endocrine assessment.

Background clinical intelligence

Automated diabetes scorecards, adherence interpretation, risk banding, and care-gap alerts generated behind the scenes.

Program dashboards

Population views for controlled vs uncontrolled diabetics, overdue retina screening, foot exam closure, thyroid recall, and follow-up leakage.

Website showcase with visuals and workflow narrative

These mockups demonstrate how Techunison can present endocrinology implementation depth visually on Techunison.com.

Population Dashboard

Specialty analytics that move beyond basic EMR reporting

Track active endocrine cohorts, HbA1c control trends, high-risk patient lists, due screenings, and action queues across clinics or provider groups.

Encounter UI

Structured endocrine consultation with scorecards in the background

Nurse intake, specialist SOAP, labs, complication review, plan, and auto-generated alerts sit together in one consultation experience.

Patient Engagement

Recall, labs, and education made visible to the patient

Longitudinal follow-up becomes stronger when patients can see visit schedules, trend summaries, tasks, and communication prompts clearly.

Positioning line for Techunison.com

From structured diabetes follow-up to endocrinology population dashboards, Techunison helps specialty clinics run as connected digital care systems on Frappe Health.

Endocrinology and diabetes specialty workflow

This is the flow Techunison can showcase as a practical, implementation-led specialty model rather than generic EMR language.

Check-in

Patient arrives for endocrine review, diabetes follow-up, thyroid review, obesity consult, or medication titration.

Nurse intake

Symptoms, adherence, anthropometry, vitals, key lab values, and due screening items are recorded in a standardized format.

Specialist review

The endocrinologist completes structured SOAP, complication review, assessment, medication change, counseling, and referral planning.

Background scoring

The system calculates glycemic control, adherence score, risk category, due care gaps, and next follow-up priority automatically.

Closed-loop follow-up

Prescription, labs, print summary, patient instructions, and recall actions are generated before the patient leaves the clinic.

Frappe Health implementation depth

This case study is strongest when it shows that Techunison is not just designing screens, but building the full specialty workflow stack underneath them.

Core Frappe Health foundation

Patient and patient appointment

Patient encounter and structured specialty SOAP

Vital signs and anthropometry capture

Lab values and repeat test planning

Prescription and medication workflows

Referral and follow-up scheduling

Print formats for specialist and patient use

Techunison specialty layer

Diabetes Assessment structured record

Endocrinology-specific encounter sections

Background diabetes control and risk score logic

Service checklist for clinic quality tracking

Overdue screening and follow-up alerts

Endocrine cohort dashboards and action worklists

Clinical intelligence layer: predictive and management soft alerts

Techunison extends Frappe Health with a non-interruptive decision-support layer that embeds diabetes and endocrine risk awareness directly inside the visit workflow. Instead of disruptive pop-ups, clinicians see visual cues, scorecards, banners, and side-panel alerts that support action without creating alert fatigue.

Why this matters in endocrine care

Chronic endocrine care depends on repeat visits, trend interpretation, and timely intervention.

High-risk diabetes patients can deteriorate quietly unless care gaps are made visible at the point of care.

Clinicians need alerts that are visible and actionable without interrupting the consultation.

Quality teams need one consolidated scorecard rather than a flood of disconnected alerts.

Techunison alert design principles

Sidebar panels and banners instead of pop-up alerts

One diabetes quality scorecard instead of ten separate notifications

Right information shown to the right user at the right point in the workflow

One-click actions such as Order HbA1c, Refer Eye, or Review Medication

High sensitivity for soft alerts so risk is surfaced early

D-RISK

EMR-driven diabetes risk detection for undiagnosed dysglycemia using age, BMI, hypertension status, race, and random glucose. Output can be converted into a 0–100 visual score with yellow and red thresholds for screening prompts.

Hypoglycemia risk stratification

Flags patients at elevated 12-month risk of severe hypoglycemia using variables such as prior hypoglycemia, insulin or sulfonylurea use, kidney function, ED utilization, and age. Ideal for a red safety sidebar and medication review prompt.

DPAR acute risk view

Supports urgent review logic for patients with DKA, hyperosmolar states, acute foot complications, or severe hypoglycemia, making it useful for high-priority inpatient or emergency endocrine workflows.

COMPETE II traffic-light monitoring

Tracks key diabetes variables using a green-yellow-red model. This is a strong fit for encounter headers, dashboard badges, and specialty monitoring panels that show whether the patient is at target, approaching threshold, or critically overdue.

SCORE2-Diabetes

Brings cardio-renal risk visibility into Type 2 Diabetes care using age, smoking, blood pressure, cholesterol, HbA1c, and kidney function. This is valuable when nudging clinicians toward cardio-renal protective therapies.

Predictive and management alert strategy

Predictive soft alerts

Undiagnosed diabetes screening when risk is high but diagnosis or recent HbA1c is missing

Prediabetes transition alerts when results move into risk ranges

Rising glucose or HbA1c trend warnings before overt deterioration

Hospitalization risk prompts for vulnerable endocrine populations

Management soft alerts

Overdue foot exam, retina screening, or kidney monitoring

Therapeutic inertia flags when HbA1c remains above target without treatment change

Hypoglycemia safety alerts for insulin or sulfonylurea users at risk

Cardio-renal protection prompts for T2DM with CKD or cardiovascular disease

Signature UI Concept

One diabetes quality scorecard instead of multiple fragmented alerts

Techunison’s strongest implementation pattern is a unified quality scorecard in the patient summary area. The panel can display glycemic control score, complication risk, care gaps, follow-up priority, and one-click actions. That gives clinicians a risk-aware consultation experience without flooding them with interruptive alerts.

Wearables and connected device layer for endocrine remote monitoring

For diabetes and chronic endocrine programs, the next step after structured visits is connected monitoring. Techunison extends the endocrine workflow with wearable-device ingestion, remote review queues, and escalation logic that helps care teams intervene between visits.

RPM

Connected device categories

Continuous glucose monitoring streams and daily trend summaries

Bluetooth glucometers for home blood sugar capture

Smart blood pressure devices for endocrine patients with hypertension risk

Connected weighing scales for obesity and metabolic syndrome follow-up

Activity and step-count integration for adherence and lifestyle programs

Care

How Techunison uses wearables inside the workflow

Device readings flow into the patient’s longitudinal endocrine record

Out-of-range patterns create soft alerts, not noisy pop-ups

Nurse worklists identify who needs outreach first

Tele-follow-up can be triggered before the next in-person visit

Population dashboards show trend deterioration across the entire program

Remote Monitoring Command View

From device data to actionable endocrine care coordination

Connected data becomes useful only when it drives nurse outreach, tele-consults, medication review, and specialist escalation. Techunison structures those next steps directly inside the care workflow.

Clinical Use Cases

Where wearables strengthen the case study

Diabetes: CGM and glucometer trends surface hypoglycemia risk, persistent hyperglycemia, and time-in-range deterioration.

Obesity: Weight and activity data support follow-up plans, counseling, and adherence review.

Cardio-metabolic overlap: BP trends support combined endocrine and hypertension review.

Post-visit monitoring: Instead of waiting 30 to 90 days for the next clinic visit, the care team can see whether the plan is actually working.

Escalation Model

Example soft-alert logic: low glucose event → nurse outreach; repeated hyperglycemia trend → doctor callback; elevated BP trend → combined endocrine review; weight gain velocity → dietician counseling task.

Embedded UI Concept

Wearables and remote monitoring dashboard inside the case study

Why wearables belong in an endocrinology case study

Structured encounters show what happened during the visit. Wearables show what is happening between visits. Together, they turn endocrinology into a true longitudinal care program.

Automated diabetes scorecards and how wearables strengthen clinical scoring

This case study becomes more credible when the platform shows not only dashboards and device feeds, but also how those inputs are converted into practical clinical scorecards. In Techunison’s endocrinology model, the scorecard layer is read-only, background-calculated, and designed for reliability first. Wearables do not replace clinical assessment. They improve timeliness, trend visibility, and follow-up decisions between visits.

Background scorecard fields

BMI — auto-calculated from height and weight

BP Status — normal, elevated, or high

Glycemic Control Score — main diabetes control score

Complication Risk Score — additional risk burden

Adherence Score — based on medication, diet, and exercise adherence

Total Diabetes Score — combined summary score

Risk Category — low, moderate, high, or critical

Service Follow-up Score — operational quality tracking

Next Follow-up Priority — routine, early, or urgent

Auto Alerts — generated read-only summary for the team

RPM

How wearable devices improve the scorecard model

Connected glucometers and CGM trends strengthen glycemic review between visits.

Smart blood pressure devices improve BP status accuracy over time, instead of relying on a single reading.

Connected weight scales improve BMI and obesity trend tracking.

Activity trackers make exercise adherence more measurable rather than purely self-reported.

Wearables help surface deterioration earlier, which improves follow-up priority and care-gap closure.

The strongest design choice is to keep the scorecard stable and easy to trust. Device data should enrich the score logic and trigger earlier alerts, but the scorecard itself should remain interpretable for doctors, nurses, and coordinators.

A. Glycemic Control Score

Simple, dependable first-version logic

HbA1c <7 = 25

HbA1c 7–8 = 18

HbA1c 8.1–9 = 10

HbA1c >9 = 5

FBS <130 = 20

FBS 130–180 = 12

FBS >180 = 5

PPBS <180 = 15

PPBS 180–250 = 8

PPBS >250 = 3

B. Vitals / Body Score

Body and blood-pressure contribution

BMI <25 = 15

BMI 25–30 = 10

BMI >30 = 5

BP <130/80 = 15

BP 130–139 / 80–89 = 10

BP ≥140/90 = 5

Wearable BP devices and connected scales make this part of the score more longitudinal and less dependent on a single clinic snapshot.

C. Adherence Score

Operationally practical adherence scoring

Medication Adherence — Good = 10

Medication Adherence — Partial = 5

Medication Adherence — Poor = 0

Diet Adherence — Good = 5

Exercise Adherence — Good = 5

Total possible example: 100. Activity and wearable engagement signals can support the exercise side of adherence without overcomplicating the model.

Risk category rule

How the platform decides follow-up intensity

80–100 = Controlled → routine follow-up

60–79 = Moderate Risk → follow-up in 30 days

<40 = Critical → immediate review or escalation

This is what makes the scorecard valuable operationally. It does not just summarize data. It drives a visible next action for the clinic team.

Hard override rules

Overrides matter more than the numeric score

HbA1c >10 → High or Critical

FBS >250 → High or Critical

Foot ulcer present → High

Nephropathy present → High

Frequent hypoglycemia → Urgent review

This is a clinically important design principle. A simple total score is useful, but it must never suppress red-flag conditions. The override layer keeps the model safe and usable.

Why wearables are powerful here

Without wearables

Scores depend heavily on episodic clinic visits

BP and weight may reflect only one point in time

Adherence is largely self-reported

Deterioration may be missed between visits

With wearables and connected devices

Trend-based scoring becomes more credible

Auto alerts can surface earlier based on real-world readings

Follow-up priority becomes more dynamic and timely

The scorecard becomes a longitudinal care-management tool, not just a visit summary

Techunison positioning

What this adds to the case study narrative

By adding the scorecard model to the wearable-device story, Techunison shows something much stronger than remote monitoring. It shows how device data, clinic inputs, and specialist review come together in one Frappe Health workflow to produce interpretable clinical scores, care-gap alerts, and operational follow-up actions. That is the difference between a device integration demo and a true endocrinology digital-care platform.

Published RPM implementation evidence and what it means for this case study

To make the wearable and remote-monitoring story more credible, this case study should show that Techunison’s design choices align with what published implementation research has already found in real diabetes remote-monitoring programs. The point is not only that RPM can improve chronic-care access. The point is that success depends on how the workflow is delivered, staffed, escalated, and adapted across sites.

What the study shows

A mixed-methods analysis published in 2023 examined diabetes remote monitoring across South Carolina primary care clinics and found that delivery strategies varied by clinic context, staffing, leadership buy-in, resources, patient needs, and inter-site communication. The core lesson is highly relevant for Techunison: RPM programs cannot be copied blindly from one site to another. They need a strong platform core with local workflow flexibility.

Why that fits the Techunison model

That is exactly how this endocrinology case study is positioned. Frappe Health acts as the common operating layer, while site-level nurse workflows, escalation rules, dashboards, and patient-engagement processes can be tuned for specialist clinics, community centers, and larger network programs.

Implementation lesson 1

Central coordination with local ownership

The South Carolina RPM model used centralized oversight with local sites retaining responsibility for individual patient care. That is a strong design pattern for Sai Swasthya and Techunison: central command dashboards and AI monitoring, combined with local clinician accountability and follow-up execution.

Implementation lesson 2

Cellular and easy-to-use device models matter

The program used cellularly enabled monitoring devices that transmitted home glucose readings for provider review. This supports a practical Techunison principle: where smartphone dependence is a barrier, device and connectivity choices should reduce patient-side friction as much as possible.

Implementation lesson 3

Rural and community settings need workflow support

The published analysis emphasized barriers in underserved and community settings, but also showed that focused training and support can improve RPM delivery. This is why training, onboarding, nurse worklists, escalation protocols, and command-center visibility are not optional extras in the Techunison model. They are part of the product.

Operational implications for the case study

What to highlight

RPM workflow must be adapted to clinic realities rather than imposed as a rigid template

Leadership buy-in and staffing design materially affect success

Communication between sites matters when scaling beyond a single clinic

Implementation support is as important as the device integration itself

How Techunison responds

Role-based nurse, doctor, and coordinator workflows

Dashboard-driven central oversight with local action ownership

Device-to-platform integration designed for low-friction patient use

Training, playbooks, and escalation pathways built into deployment planning

Case study positioning

Why this section strengthens the website narrative

Adding evidence from real-world RPM implementation moves the story from “we can connect devices” to “we understand how RPM programs actually succeed at scale.” That is the level of credibility Techunison should project in an endocrinology and diabetes case study.

Sai Swasthya wearable ecosystem: business model, deployment strategy, and scale economics

This case study becomes much stronger when the wearables layer is not presented as a gadget add-on, but as a scalable chronic-care monitoring model. The core idea is simple: Techunison is not positioning Sai Swasthya as a device company. The real platform is population health management, with blood sugar and blood pressure devices acting as continuous data inputs into Frappe Health, AI alerts, and command-center workflows.

India cost advantage

India creates a major scale opportunity because blood sugar and blood pressure monitoring can be deployed at materially lower cost than Western RPM models. This enables donor-funded or subsidized deployment at scale while still supporting strong chronic-care oversight.

Global RPM upside

The same integration stack can support commercial remote patient monitoring programs for private hospitals and international markets. That creates a hybrid model where commercial RPM can subsidize rural and philanthropic care.

Platform moat

The durable value is not hardware margin. It is the combination of device integration, longitudinal care workflows, AI-driven risk scoring, and command-center visibility across the network.

Indicative device economics

India-oriented cost model

CGM wearable: roughly ₹4,000–₹5,500 per sensor for 15 days

Monthly CGM use: roughly ₹8,000–₹10,000 per patient for two sensors

Basic glucometer: roughly ₹500–₹1,300 for the device

Standard BP monitor: roughly ₹1,000–₹3,000

Wearable or smart BP device: roughly ₹4,000–₹15,000

For Sai Swasthya, the practical blended model is not to use CGM for everyone. A more realistic deployment is glucometer-plus-strips for the majority, CGM for selected high-risk patients, and blood pressure monitoring broadly across the chronic-care cohort.

International benchmark

Global RPM economics

US CGM benchmark: roughly $60–$120 per month

Remote BP kits: roughly $80–$200 per device

Commercial RPM pricing: roughly $50–$120 per patient per month

Middle East opportunity band: roughly $40–$80 per patient per month

India private hospital RPM: roughly ₹1,500–₹3,000 per patient per month

That differential is what makes the hybrid model attractive. India can serve as the operating-scale engine, while global and private RPM programs create financial sustainability.

Two-track operating model

Track 1: Sai Swasthya India

Donor-funded or subsidized devices for diabetes and hypertension patients

Monitoring delivered through Sai Swasthya centers and care coordinators

AI alerts embedded into Frappe Health and central dashboards

Affordable blended cost per patient using device-tier stratification

Track 2: Global and private RPM

Commercial subscription model for hospitals and health systems

Remote monitoring bundled with dashboards, alert logic, and care workflows

Higher-value service model for private and international markets

Potential revenue stream that helps subsidize rural chronic-care programs

Pilot phase

1,000 patients. A practical first phase uses glucometer-plus-strips for most patients, CGM for selected high-risk patients, and BP devices widely. This is the phase where integration, nurse worklists, and escalation thresholds are tuned.

Scale phase

10,000 patients. AI risk scoring, telemedicine integration, and operational dashboards move from useful to essential. At this stage, the program behaves like a population health service rather than a device pilot.

Command-center phase

100,000 patients. National dashboards, predictive analytics, and multi-center care coordination become the differentiator. This is where Sai Swasthya can position itself as a serious wearable-enabled public health network.

Architecture fit

How the wearable business model fits the Techunison stack

Wearable Device → Mobile App → API Gateway → Frappe Health → AI Engine → Command Center.

Device layer with BeatO, Abbott, Omron, or other supported partners

Middleware using app sync, APIs, MQTT, or vendor SDK integrations

Frappe Health as the core source of patient, visit, and longitudinal care records

AI layer for trend detection, risk scoring, and escalation logic

Command-center dashboards for center-wise and population-wide visibility

Hard truth and strategic clarity

Why this model is credible

The strongest insight in the Sai Swasthya wearable plan is strategic discipline: do not try to become a hardware manufacturer. Hardware margins are weak and device development slows execution. The scalable value sits in the platform, the AI layer, the data integration, and the operational workflows around chronic disease management.

That is exactly why this business section belongs inside the Techunison case study. It positions the solution as a serious care platform with economic logic, not just a digital health concept.

Why this matters for clinic operations

For specialists

Faster, more consistent documentation

Less cognitive load during repeat follow-up visits

Better visibility into prior trends and current risk

Clearer referral and recall planning

For management

Controlled vs uncontrolled diabetic population view

Complication screening compliance measurement

Missed follow-up and due-lab worklists

Specialty program performance across locations

What Techunison can highlight as outcomes

These are strong website-level outcome statements even when the case study is presented as a capability showcase rather than a published client metrics page.

Better

specialty documentation consistency across diabetes and endocrine visits

Earlier

identification of uncontrolled and high-risk patients needing tighter follow-up

Stronger

closure of foot exam, retina screening, lab repeat, referral, and wearable-triggered outreach care gaps

Clearer

program visibility for leadership, quality teams, and care coordinators

Suggested closing copy

A digital endocrine clinic, not just another EMR screen

Techunison helps endocrinology and diabetes programs move from fragmented visit documentation to structured, measurable, and scalable specialty care on Frappe Health, with remote monitoring and wearable-device workflows included where needed.

Talk to an expert

Request a Demo